Targeting PI3K Pathway Course

Targeting PI3K Pathway Course is organized by Society for Translational Oncology (STO).

Released: 05/04/2021 
Expires: 05/04/2022 

Target Audience
Physicians who wish to advance their current knowledge of the PI3K pathway in cancer biology and its clinical impact.

Learning Objectives:
• Understand the role of the PI3K pathway in cancer biology and the clinical impact of available therapeutics targeting this pathway.
• Learn about tissue and plasma-based testing strategies for PI3K-activating mutations
• Learn about the most common adverse events associated with PI3K pathway inhibitors and their management